Eliquis 2.5 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FM2TT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,176
Award facts
- Contract value 100% obligated
- $11,176.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 20, 2026, the Defense Logistics Agency awarded a delivery order valued at $11,176.07 to AmerisourceBergen Drug Corp for the supply of Eliquis 2.5 mg tablets (60-count units). The contract, which is non-set-aside and competitively awarded on a firm fixed-price basis, is scheduled for ultimate completion by January 21, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., which is the parent organization and also holds significant federal contracting relationships. The parent company, Cencora, maintains a separate large-value IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. Both entities have demonstrated consistent capability in fulfilling federal medical supply needs across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The delivery of Eliquis, a critical cardiovascular medication, reflects AmerisourceBergen's role as a key supplier supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FM2TT?
SPE2DR26FM2TT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FM2TT worth?
The government has obligated $11,176 on SPE2DR26FM2TT.
Is contract SPE2DR26FM2TT an order under another contract?
Yes. SPE2DR26FM2TT is a delivery order under SPE2DR25D3501, an indefinite delivery contract.
Was contract SPE2DR26FM2TT competed?
The extent of competition for SPE2DR26FM2TT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award